Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan
Esophagus · 2023
DOI: 10.1007/s10388-023-01002-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Esophagus, 2023. Verfasst von Akihiko Okamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Esophageal Surgery, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Although neoadjuvant treatment (NAT) has become the standard of care for patients with locally advanced esophageal cancer, the risk of recurrence remains high. The risk must be predicted accurately, so that appropriate adjuvant therapy can be planned. We aimed to develop a model predicting recurrence of esophageal squamous cell carcinoma (ESCC) in patients who received NAT before esophagectomy. METHODS: This nationwide study included 3874 patients from 85 institutions. Patients who underwent NAT and then surgery for ESCC were eligible. We developed a Cox proportional hazards model and created a nomogram to predict disease recurrence after NAT and curative esophagectomy. RESULTS: Of the patients, 268 (6.9%), 1280 (33.0%), 2006 (51.8%), and 320 (8.3%) had clinical stage I, II, III, and IV tumors, respectively. The 5-year recurrence rate was 45.1% (95% confidence interval 43.4%-46.7%). Multivariable analysis revealed that body mass index, type of neoadjuvant treatment, primary tumor location, operative blood loss, pathological tumor stage, pathological therapeutic effect, and leakage were independently associated with disease recurrence. Using 13 commonly measured perioperative variables, we created a predictive nomogram, and the area under the curve was 0.783 (95% confidence interval 0.766-0.800). This nomogram was also adequately validated internally and had excellent calibration capacity (calibration slope, 0.992). CONCLUSIONS: The model developed in this study adequately predicted ESCC recurrence in patients who underwent NAT and then esophagectomy. Further research with this nomogram is needed to assess the effect of adjuvant therapy in patients at high risk for recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Esophageal Surgery, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
- Department of Esophageal Surgery, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. masayuki.watanabe@jfcr.or.jp.
- Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan.
- Department of Surgery, School of Medicine, Keio University, Tokyo, Japan.
- Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
- Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan.
ORCID-Profile: Masayuki Watanabe
Zitieren
APA
Okamura, A., Watanabe, M., Okui, J., Matsuda, S., Takemura, R., Kawakubo, H., Takeuchi, H., Muto, M., Kakeji, Y., Kitagawa, Y., & Doki, Y. (2023). Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan. Esophagus. https://doi.org/10.1007/s10388-023-01002-2
Vancouver
Okamura A, Watanabe M, Okui J, Matsuda S, Takemura R, Kawakubo H, et al. Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan. Esophagus. 2023. doi:10.1007/s10388-023-01002-2
BibTeX
@article{Okamura2023,
author = {Okamura, Akihiko and Watanabe, Masayuki and Okui, Jun and Matsuda, Satoru and Takemura, Ryo and Kawakubo, Hirofumi and Takeuchi, Hiroya and Muto, Manabu and Kakeji, Yoshihiro and Kitagawa, Yuko and Doki, Yuichiro},
title = {Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan},
journal = {Esophagus},
year = {2023},
doi = {10.1007/s10388-023-01002-2}
}
EUVIMED